MedPath

The therapeutic effect of nano-Curcumin on skin lesion of psoriasis

Phase 2
Conditions
Psoriasis.
Psoriasis vulgaris
L40.0
Registration Number
IRCT20181217042030N1
Lead Sponsor
Gorgan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
10
Inclusion Criteria

Parallel lesional skin of Psoriatic patient
lesions from mild or severe form of disease
Age >+18
Signing the informed consent form

Exclusion Criteria

Pregnant and lactation
Suffering from autoimmune or other inflammation diseases
Suffering from Cirrhosis and Hepatic disease
Suffering from Metabolic syndrome
Suffering from severe Renal disease
Allergic reaction to Curcumin

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath